Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a post hoc analysis of the randomized FLOWER-MI trial

Archive ouverte

Tea, Victoria | Morelle, Jean-François | Gallet, Romain | Cayla, Guillaume | Lemesle, Gilles | Lhermusier, Thibault | Dillinger, Jean-Guillaume | Ducrocq, Gregory | Angouvant, Denis | Cottin, Yves | Chamandi, Chekrallah | Le Bras, Alicia | Steg, Philippe Gabriel | Montalescot, Gilles | Nelson, Anaïs Charles | Simon, Tabassome | Chatellier, Gilles | Danchin, Nicolas | Puymirat, Etienne

Edité par CCSD ; Elsevier ; Société française de cardiologie [2008-....] -

International audience. Background: in patients with ST-segment elevation myocardial infarction and multivessel disease, percutaneous coronary intervention for non-culprit lesions is superior to treatment of the culprit lesion alone. The optimal timing for non-infarct-related artery revascularization - immediate versus staged - has not been investigated adequately. Aim: we aimed to assess clinical outcomes at 1 year in patients with ST-segment elevation myocardial infarction with multivessel disease using immediate versus staged non-infarct-related artery revascularization. Methods: outcomes were analysed in patients from the randomized FLOWER-MI trial, in whom, after successful primary percutaneous coronary intervention, non-culprit lesions were assessed using fractional flow reserve or angiography during the index procedure or during a staged procedure during the initial hospital stay, ≤5 days after the index procedure. The primary outcome was a composite of all-cause death, non-fatal myocardial infarction and unplanned hospitalization with urgent revascularization at 1 year. Results: among 1171 patients enrolled in this study, 1119 (96.2%) had complete revascularization performed during a staged procedure, and 44 (3.8%) at the time of primary percutaneous coronary intervention. During follow-up, a primary outcome event occurred in one of the patients (2.3%) with an immediate strategy and in 55 patients (4.9%) with a staged strategy (adjusted hazard ratio 1.44, 95% confidence interval 0.39-12.69; P=0.64). Conclusions: staged non-infarct-related artery complete revascularization was the strategy preferred by investigators in practice in patients with ST-segment elevation myocardial infarction with multivessel disease. This strategy was not superior to immediate revascularization, which, in the context of this trial, was used in a small proportion of patients. Further randomized studies are needed to confirm these observational findings.

Consulter en ligne

Suggestions

Du même auteur

Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial

Archive ouverte | Tea, Victoria | CCSD

International audience

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

Archive ouverte | Puymirat, Etienne | CCSD

International audience. In patients with ST-elevation myocardial infarction (STEMI) who have multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions (complete revascularization) is super...

Three-Year Outcomes With Fractional Flow Reserve–Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction

Archive ouverte | Puymirat, Etienne | CCSD

International audience. BACKGROUND: In patients with multivessel disease with successful primary percutaneous coronary intervention for ST-segment–elevation myocardial infarction, the FLOWER-MI trial (Flow Evaluatio...

Chargement des enrichissements...